You have 9 free searches left this month | for more free features.

DTP-HB-Hib Vaccine

Showing 1 - 25 of 8,653

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diphtheria Vaccine Adverse Reaction, Tetanus Vaccine Adverse Reaction, Pertussis Vaccine Adverse Reaction Trial in Bandung

Not yet recruiting
  • Diphtheria Vaccine Adverse Reaction
  • +4 more
  • Recombinant Hepatitis B new Bulk vaccine
  • +3 more
  • Bandung, West Java, Indonesia
  • +2 more
Jul 29, 2022

Immunogenicity, Safety Trial in Bandung (Recombinant Hepatitis B + DTP-HB-Hib, Hep B + Pentabio (registered))

Completed
  • Immunogenicity
  • Safety
  • Recombinant Hepatitis B + DTP-HB-Hib
  • Hep B + Pentabio (registered)
  • Bandung, West Java, Indonesia
  • +2 more
Jan 13, 2022

Meningococcal Infections Trial in Worldwide (MenACYW conjugate vaccine, Meningococcal group A, C, W-135, and Y conjugate

Active, not recruiting
  • Meningococcal Infections
  • MenACYW conjugate vaccine
  • +5 more
  • Chlumec Nad Cidlinou, Czechia
  • +30 more
Jan 4, 2023

Meningitis, Meningococcal Trial in Worldwide (MenACYW conjugate vaccine, MMR, Varicella)

Completed
  • Meningitis, Meningococcal
  • MenACYW conjugate vaccine
  • +4 more
  • Ansan, Korea, Republic of
  • +36 more
Mar 24, 2022

Poliomyelitis, Polio Trial in Dhaka, Gujranwala, Karachi (Sabin Strain Inactivated Poliovirus Vaccine)

Not yet recruiting
  • Poliomyelitis
  • Polio
  • Sabin Strain Inactivated Poliovirus Vaccine
  • Dhaka, Bangladesh
  • +2 more
Apr 28, 2023

Immune Response to DTP-HB-Hib Vaccine Trial in Pune, Chennai (biological, device, other)

Terminated
  • Immune Response to DTP-HB-Hib Vaccine
  • DTP-HB-Hib vaccine
  • +2 more
  • Pune, Maharashtr, India
  • +2 more
Sep 7, 2018

Infections, Rotavirus Trial in South Africa (Rotarix, Placebo, Tritanrix-HB+Hib)

Completed
  • Infections, Rotavirus
  • Rotarix
  • +3 more
  • Attridgerville, Gauteng, South Africa
  • +5 more
Nov 4, 2020

Diseases Specified as Adverse Events of Special Interest, of

Active, not recruiting
  • Malaria
  • Malaria Vaccines
  • Blood collection
  • Ouagadougou, Burkina Faso
  • +4 more
Oct 18, 2021

Diphtheria Trial in Schoenau Am Koenigssee, Milano, Santiago de Compostela (DTPa-HBV-IPV/Hib, DTaP5-HBV-IPV-Hib, Pneumococcal

Completed
  • Diphtheria
  • DTPa-HBV-IPV/Hib
  • +2 more
  • Rosenheim, Bayern, Germany
  • +19 more
Jan 24, 2023

National Vaccine Adverse Event Reporting Survey and Etiology

Recruiting
  • COVID-19
  • +12 more
  • vaccinated
  • Northglenn, Colorado
    Neuroganics LLC
Mar 3, 2022

Vaccine, Pain Trial in Ordu (Cold Massage Group, ShotBlocker© Group)

Active, not recruiting
  • Vaccine
  • Pain
  • Cold Massage Group
  • ShotBlocker© Group
  • Ordu, Turkey
    Dilek alemdar
Mar 5, 2023

Diphtheria, Tetanus, Pertussis Trial in Seoul (DTP-HepB-IPV-Hib vaccine, DTP-HepB-Hib vaccine & IPV)

Completed
  • Diphtheria
  • +5 more
  • DTP-HepB-IPV-Hib vaccine
  • DTP-HepB-Hib vaccine & IPV
  • Seoul, Korea, Republic of
    Korea University Guro Hospital
Aug 27, 2019

Metastatic Colorectal Cancer Trial in Toronto (Hydroxychloroquine, Irinotecan, Leucovorin)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 24, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Columbus (Best Practice, Supportive Care, Survey

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Best Practice
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Oct 17, 2023

HIV Prevention, Pre-exposure Prophylaxis, STI Trial in Seattle (Health service - home-based PrEP monitoring)

Recruiting
  • HIV Prevention
  • +2 more
  • Health service - home-based PrEP monitoring
  • Seattle, Washington
    University of Washington
May 12, 2023

Malaria Trial in Worldwide (Blood sampling, Assessment of body temperature)

Recruiting
  • Malaria
  • Malaria Vaccines
  • Blood sampling
  • Assessment of body temperature
  • Nouna, Burkina Faso
  • +11 more
Sep 8, 2022

Acute Lymphoblastic Leukemia Trial in Halifax (Prevnar®13, Pneumovax® 23, Pediacel®)

Completed
  • Acute Lymphoblastic Leukemia
  • Prevnar®13
  • +2 more
  • Halifax, Nova Scotia, Canada
    IWK Health Centre
Jun 22, 2022

Tuberculosis Trial in Banjul (GSK's investigational vaccine 692342, Tritanrix™ HB+Hib, Prevnar™)

Completed
  • Tuberculosis
  • GSK's investigational vaccine 692342
  • +4 more
  • Banjul, Gambia
    GSK Investigational Site
Jun 11, 2019

Hb Scope: A Multi-Center Validation Trial

Not yet recruiting
  • Hemoglobin
  • Hemodialysis
  • Hb Scope APP
  • (no location specified)
May 1, 2023

Hepatitis B Trial in Bobo-Dioulasso (birth dose vaccination against hepatitis B strategy)

Recruiting
  • Hepatitis B
  • birth dose vaccination against hepatitis B strategy
  • Bobo-Dioulasso, Dafra, Burkina Faso
  • +1 more
Apr 19, 2022

Diphtheria, Tetanus, Pertussis Trial (LBVD (Hexavalent vaccine), Pentavalent vaccine and Inactivated Polio vaccine (Sabin

Not yet recruiting
  • Diphtheria
  • +5 more
  • LBVD (Hexavalent vaccine)
  • Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains)
  • (no location specified)
Jul 13, 2022

Program to Determine Product Specific Rates of Invasive Hib

Completed
  • Haemophilus Infections
  • +4 more
  • DTaP-IPV/Hib
  • Albany, California
  • +58 more
Apr 21, 2022

Meningococcal Disease, Pneumococcal Disease, Haemophilus Influenzae Serotype b Disease Trial in London (Menjugate, Menitorix,

Completed
  • Meningococcal Disease
  • +4 more
  • Menjugate
  • +2 more
  • London, United Kingdom
    St George's Vaccien Institute
Sep 29, 2020

Prostate Cancer Metastatic Trial in New York, Knoxville (HB-302/HB-301 Alternating 2-Vector Therapy)

Recruiting
  • Prostate Cancer Metastatic
  • HB-302/HB-301 Alternating 2-Vector Therapy
  • New York, New York
  • +1 more
Feb 1, 2023

Parkinson Disease Trial (HB- adMSCs (Hope Biosciences adipose derived mesenchymal stem cells))

Available
  • Parkinson Disease
  • HB- adMSCs (Hope Biosciences adipose derived mesenchymal stem cells)
  • (no location specified)
Sep 20, 2023